Febe Van Maldegem

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.

Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.

Journal: Journal for immunotherapy of cancer

Published: June 03, 2026

Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.

Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.

Journal: Journal for immunotherapy of cancer

Published: November 03, 2025

Statescope: an integrative deconvolution framework for discovering cell states in tumors.

Statescope: an integrative deconvolution framework for discovering cell states in tumors.

Journal: Nature communications

Published: October 03, 2025

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Journal: Science advances

Published: November 01, 2024

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Journal: Journal for immunotherapy of cancer

Published: September 08, 2024

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.

Journal: Cancer discovery

Published: November 17, 2023

Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX.

Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX.

Journal: Nature communications

Published: October 11, 2023

Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.

Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.

Journal: Science advances

Published: July 20, 2022

Lung adenocarcinoma promotion by air pollutants.

Lung adenocarcinoma promotion by air pollutants.

Journal: Nature

Published: June 17, 2022

Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.

Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.

Journal: Nature communications

Published: March 05, 2021

Mutant KRAS at the Heart of Tumor Immune Evasion.

Mutant KRAS at the Heart of Tumor Immune Evasion.

Journal: Immunity

Published: January 18, 2020

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.

Journal: Science translational medicine

Published: February 01, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026